In Vitro Xanthine Oxidase Inhibitory Activity of Morinda citrifolia L.(Noni) Leaf and Identification of Its Xanthine Oxidase Inhibitors
J Thipwong, K Kongton, B Nupan - Trends in Sciences, 2023 - tis.wu.ac.th
Hyperuricemia causes an excessive level of uric acid in the body, which leads to the
formation of gouty arthritis and high uric acid-related diseases. To cure this condition …
formation of gouty arthritis and high uric acid-related diseases. To cure this condition …
Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
HJ Shin, JY Yoon, YO Na, JK Lee, BG Kho, TO Kim… - Plos one, 2023 - journals.plos.org
Background Hyperuricemia is common during tuberculosis (TB) treatment, especially in
association with pyrazinamide (PZA). This study investigated the relationship between major …
association with pyrazinamide (PZA). This study investigated the relationship between major …
[PDF][PDF] 基于代谢性疾病“四高症” 的中医异病同治临床辨治思路
姜玉华， 刘继法， 陈曦， 杨金生 - 中国中西医结合杂志, 2023 - cjim.cn
摘要“四高症” 是与代谢性相关的高血压病, 高血糖, 高脂血症和高尿酸血症的简称,
与代谢综合征关系密切. 这四种疾病都与生活方式失衡所引起的能量代谢异常密切相关 …
与代谢综合征关系密切. 这四种疾病都与生活方式失衡所引起的能量代谢异常密切相关 …
Cloning, Heterologous Expression, and Characterization of a Neutral Uricase from sp. CSAJ-16 in Cangshan Mountain
X Yan, W Hu, YG Zhu, QQ Liu, S Wang… - Polish Journal of …, 2023 - sciendo.com
Uricase (or Urate oxidase), a key enzyme involved in purine metabolism, is commonly used
in treating conditions such as gout, hyperuricemia, and tumor lysis syndrome. In this study, a …
in treating conditions such as gout, hyperuricemia, and tumor lysis syndrome. In this study, a …
БИОМАРКЕРЫ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ
АУ Хамадьянова, АР Валинуров… - Комплексные …, 2023 - nii-kpssz.com
Аннотация Сердечная недостаточность (СН) у детей может развиваться по разным
причинам, которые зависят от возраста. Например, в период новорожденности и в …
причинам, которые зависят от возраста. Например, в период новорожденности и в …
[HTML][HTML] Prothrombotic Effect of Serum Uric Acid in Hypertensive Patients
M Papavasileiou, D Aravantinos, G Moustakas… - Open Access Library …, 2023 - scirp.org
Aim: The purpose of this study was to investigate the possible relationship of serum uric acid
levels (SUA), in hypertensive patients treated or not, with blood clotting factors. Design and …
levels (SUA), in hypertensive patients treated or not, with blood clotting factors. Design and …
FREQUENCY OF HYPERURICEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS.
MH Bugti, F Saleem, A Dawach, V Talib… - …, 2023 - search.proquest.com
FREQUENCY OF HYPERURICEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. Page
1 NEUROQUANTOLOGY | March 2023 | Volume 21 | Issue 5| Page 1462-1467| doi …
1 NEUROQUANTOLOGY | March 2023 | Volume 21 | Issue 5| Page 1462-1467| doi …
Secretion of IL-1ß from monocytes in gout is redox independent
BM Alberts, C Bruce, K Basnayake, P Ghezzi, K Davies… - sussex.figshare.com
The proinflammatory cytokine interleukin-1ß (IL-1ß) plays important roles in immunity but is
also implicated in autoimmune disease. The most well-established mechanism of IL-1ß …
also implicated in autoimmune disease. The most well-established mechanism of IL-1ß …
HYPERURICEMIA, THE RISK FACTORS AND PHARMACOTHERAPY.
F Zita, Č Andrea, F Dominika… - Folia Pharmaceutica …, 2023 - search.ebscohost.com
Hyperuricemia is a pathologically increased concentration of uric acid in the blood and is a
risk factor for gout and the development of other diseases. The prevalence of hyperuricemia …
risk factor for gout and the development of other diseases. The prevalence of hyperuricemia …
Ryšys tarp hiperurikemijos, alkoholio ir vandens suvartojimo
A Gataveckaitė - 2023 - epublications.vu.lt
Abstract [eng] Author: Akvilė Gataveckaitė-Leonavičė Supervisor: Prof. Dr. Jolanta
Dadonienė. Work conducted at the Department of Public Health, Institute of Health Sciences …
Dadonienė. Work conducted at the Department of Public Health, Institute of Health Sciences …